Template:Cystitis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) No edit summary |
|||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
==Empiric Therapy for Acute Cystitis== | ==Empiric Therapy for Acute Cystitis== <SMALL><SMALL><SMALL><SMALL><SMALL>Adapted from ''Clin Infect Dis. 2011;52(5):e103-20.''<ref name="Gupta-2011"<ref>{{Cite journal | last1 = Gupta | first1 = K. | last2 = Hooton | first2 = TM. | last3 = Naber |first3 = KG. | last4 = Wullt | first4 = B. | last5 = Colgan | first5 = R. | last6 = Miller | first6 = LG. | last7 = Moran | first7 = GJ. | last8 = Nicolle | first8 = LE. | last9 = Raz | first9 = R. | title = International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. | journal = Clin Infect Dis | volume = 52 | issue = 5 | pages = e103-20 | month = Mar | year = 2011 | doi = 10.1093/cid/ciq257 |PMID = 21292654 }}</ref></SMALL></SMALL></SMALL></SMALL></SMALL> | ||
Line 6: | Line 6: | ||
{| style="background: #FFFFFF;" | {| style="background: #FFFFFF;" | ||
| valign=top | | | valign=top | | ||
{| style="float: left; cellpadding=0; cellspacing= 0; width: | {| style="float: left; cellpadding=0; cellspacing= 0; width: 500px;" | ||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Acute Bacterial Uncomplicated Cystitis}} | ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Acute Bacterial Uncomplicated Cystitis}} | ||
|- | |- | ||
Line 29: | Line 29: | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | '''''OR''''' '''''▸ [[Beta-lactam|β-lactam]] agents for 3-7 days''''' | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | '''''OR''''' '''''▸ [[Beta-lactam|β-lactam]] agents for 3-7 days''''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Amoxicillin-clavulanate]] 500/125 mg PO q8h or 875/125 mg PO q8h'''''<br>OR<br>▸'''''[[Cefdinir]] 300 mg PO q12h or 600 mg PO q24''''' <br>OR<br>'''''[[Cefaclor]] 250-500 mg PO q8h'''''<br>OR<br>▸'''''[[Cefpodoxime proxetil]] 100-200 mg PO q12h'''''<br>OR<br>'''''[[Cephalexin]]250-500 mg PO q6h <small> not studied well but effective</small>.''''' | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Amoxicillin-clavulanate]] 500/125 mg PO q8h or 875/125 mg PO q8h'''''<br>OR<br>▸'''''[[Cefdinir]] 300 mg PO q12h or 600 mg PO q24''''' <br>OR<br>'''''[[Cefaclor]] 250-500 mg PO q8h'''''<br>OR<br>▸'''''[[Cefpodoxime proxetil]] 100-200 mg PO q12h'''''<br>OR<br>'''''[[Cephalexin]]250-500 mg PO q6h <small> not studied well but effective</small>.''''' | ||
|- | |- | ||
|} | |} | ||
Line 36: | Line 36: | ||
{| style="background: #FFFFFF;" | {| style="background: #FFFFFF;" | ||
| valign=top | | | valign=top | | ||
{| style="float: left; cellpadding=0; cellspacing= 0; width: | {| style="float: left; cellpadding=0; cellspacing= 0; width: 500px;" | ||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Complicated/Catheter Associated Cystitis}} | ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Complicated/Catheter Associated Cystitis}} | ||
|- | |- | ||
Line 57: | Line 57: | ||
{| style="background: #FFFFFF;" | {| style="background: #FFFFFF;" | ||
| valign=top | | | valign=top | | ||
{| style="float: left; cellpadding=0; cellspacing= 0; width: | {| style="float: left; cellpadding=0; cellspacing= 0; width: 500px;" | ||
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center |{{fontcolor|#FFF|Acute Cystitis in Pregnancy}} | ! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center |{{fontcolor|#FFF|Acute Cystitis in Pregnancy}} | ||
|- | |- |
Latest revision as of 19:24, 26 February 2014
==Empiric Therapy for Acute Cystitis== Adapted from Clin Infect Dis. 2011;52(5):e103-20.[1]
|
|
- ↑ Gupta, K.; Hooton, TM.; Naber, KG.; Wullt, B.; Colgan, R.; Miller, LG.; Moran, GJ.; Nicolle, LE.; Raz, R. (2011). "International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases". Clin Infect Dis. 52 (5): e103–20. doi:10.1093/cid/ciq257. PMID 21292654. Unknown parameter
|month=
ignored (help)